<DOC>
	<DOCNO>NCT00224302</DOCNO>
	<brief_summary>We evaluate efficacy tolerability duloxetine treatment major depressive episode course psychotic disorder</brief_summary>
	<brief_title>Treatment MDEs During Course Psychotic Disorders With Duloxetine</brief_title>
	<detailed_description>Major depressive episode ( MDE ) frequently occur course schizophrenic psychosis , `` post-psychotic '' depression , also independently psychotic episode . A number clinical study report application different antidepressive substance , Imipramine , Reboxetine Venlafaxine . In general , treatment schizophrenic patient antidepressive drug consider necessary save , result therapeutic guideline different psychiatric society . However , since 5 10 % schizophrenic patient commit suicide , still much effort necessary order improve treatment affective symptom schizophrenic psychoses.The recently introduce antidepressive substance Duloxetine selectively inhibit SSNRI reuptake serotonine noradrenaline synaptic cleft . Duloxetine proven antidepressive , anxiolytic analgetic series multi-centre , placebo-controlled investigation . Based consideration successful experience single case report aim investigate therapeutic effect duloxetine patient lifetime diagnosis schizophrenic spectrum .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Major depressive episode , Severity : CDSS least 8 point HAMD least 15 point , indication treatment duloxetine Lifetime diagnosis psychotic disorder ( PANSS positive scale 15 point ) Age 18 65 , Informed consent No informed consent , Contraindications respect duloxetine , Gravidity miss anticonceptive safety Substance dependance ( excluded nicotin )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Schizophrenia ,</keyword>
	<keyword>schizoaffective disorder ,</keyword>
	<keyword>major depressive episode ,</keyword>
	<keyword>combination ,</keyword>
	<keyword>duloxetine</keyword>
</DOC>